AstraZeneca’s $2.5 Billion Beijing Investment: A Game-Changer for R&D and Collaboration March 27, 2025 Pharma & Biotech AstraZeneca's $2.5 billion investment in Beijing establishes a cutting-edge R&D hub, boosting innovation, workforce growth, and global healthcare advancements. Continue Reading
